| NCT ID | NCT02967068 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Aortitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2016-11 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2016-11 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to collect existing tissue specimens from subjects enrolled in Vasculitis Clinical Research Consortium (VCRC) studies. Analysis of these tissue specimens and linked clinical data collected through VCRC studies may lead to the identification and development of a series of translational research projects. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.
Eligibility Criteria
Inclusion Criteria: * A participant will be deemed eligible for this study if the participant is/was enrolled in another one of the VCRC observational/longitudinal protocols (5502, 5503, 5504, 5505, 5506, 5507, 5563) and/or one of the VCRC interventional studies (5522, 5523, 5526, 5527, or 5562). Exclusion Criteria: * Inability to give informed consent (or their guardians in the case of children) and to sign the consent form. * Unwilling to allow the use of their tissue for research.
Contact & Investigator
Katie Doyle
✉ Kathryn.Logue@pennmedicine.upenn.eduPeter A Merkel, MD, MPH
STUDY CHAIR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT02967068 clinical trial?
This trial is open to participants of all sexes, studying Aortitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02967068 currently recruiting?
Yes, NCT02967068 is actively recruiting participants. Contact the research team at Kathryn.Logue@pennmedicine.upenn.edu for enrollment information.
Where is the NCT02967068 trial being conducted?
This trial is being conducted at Boston, United States, Boston, United States, Cleveland, United States, Philadelphia, United States and 4 additional locations.
Who is sponsoring the NCT02967068 clinical trial?
NCT02967068 is sponsored by University of Pennsylvania. The principal investigator is Peter A Merkel, MD, MPH at University of Pennsylvania. The trial plans to enroll 1,000 participants.